Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment
- PMID: 24919831
- PMCID: PMC5574197
- DOI: 10.1177/0962280214537344
Quantitative imaging biomarkers: a review of statistical methods for technical performance assessment
Abstract
Technological developments and greater rigor in the quantitative measurement of biological features in medical images have given rise to an increased interest in using quantitative imaging biomarkers to measure changes in these features. Critical to the performance of a quantitative imaging biomarker in preclinical or clinical settings are three primary metrology areas of interest: measurement linearity and bias, repeatability, and the ability to consistently reproduce equivalent results when conditions change, as would be expected in any clinical trial. Unfortunately, performance studies to date differ greatly in designs, analysis method, and metrics used to assess a quantitative imaging biomarker for clinical use. It is therefore difficult or not possible to integrate results from different studies or to use reported results to design studies. The Radiological Society of North America and the Quantitative Imaging Biomarker Alliance with technical, radiological, and statistical experts developed a set of technical performance analysis methods, metrics, and study designs that provide terminology, metrics, and methods consistent with widely accepted metrological standards. This document provides a consistent framework for the conduct and evaluation of quantitative imaging biomarker performance studies so that results from multiple studies can be compared, contrasted, or combined.
Keywords: agreement; bias; imaging biomarkers; linearity; precision; quantitative imaging; reliability; repeatability; reproducibility.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.
Figures
References
-
- Mueller DK, Kutscherenko A, Bartel H, Vlassenbroek A, Ourednicek P, Erckenbrecht J. Phantom-less QCT BMD system as screening tool for osteoporosis without additional radiation. European journal of radiology. 2011;79:375–81. - PubMed
-
- Hamburg MA, Collins FS. The path to personalized medicine. The New England journal of medicine. 2010;363:301–4. - PubMed
-
- Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics. 2001;69:89–95. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
